Natalya I. Voloshchuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalya I. Voloshchuk has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Igor V. Ukrainets
Department of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska St., 61002 Kharkiv, Ukraine
9 shared publications - Svitlana V. Shishkina
Institute of Organic Chemistry National Academy of Sciences of Ukraine, Akademik Kukhar Street 5, Kyiv, 02660
9 shared publications - Anna A. Burian
Department of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska St., 61002 Kharkiv, Ukraine
6 shared publications - Galina Sim
Department of Pharmaceutical Chemistry, Far Eastern State Medical University, 35 Murav’eva-Amurskogo St., 680000 Khabarovsk, Russia
6 shared publications - Ganna M. Hamza
Department of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska St., 61002 Kharkiv, Ukraine
4 shared publications - N. A. Tsubanova
Andrei Krupynskyi Lviv Medical Academy, Lviv, Ukraine
4 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 30 (2) , 364-376
THE KISPEPTINERGIC SYSTEM IN THE REGULATION OF REPRODUCTION, STRESS AND ENERGY HOMEOSTASIS
Study of the mechanisms of functioning of the reproductive system, the influence of sex hormones on the functions of the central nervous system and the organization of behavior is one of the urgent tasks of modern science. Kisspeptin and its receptors (Kiss-R) have been identified in lower and higher vertebrates. Recently, kisspeptin is more often considered as a behavioral hormone that affects the limbic system as a whole, including the hypothalamic-pituitary-gonadal and hypothalamicpituitary-adrenal neuroendocrine axes. In turn, these circuits regulate the activity of signaling neurotransmitters and hormones, namely gonadal steroids and stress hormones. It is known that in the central nervous system, kisspeptin acts as an endocrine regulator of sexual development and human reproductive functions. This review discusses the role of kisspeptin for the neuroendocrine regulation of gonadotropin-releasing hormone secretion. Kisspeptinergic neurons are now recognized as central regulators responsible for transmitting homeostatic information to GnRH neurons. KISS1R play a key role in initiating sexual maturation and regulating processes in the human reproductive system. Numerous studies in recent years have established the connection of kisspeptin with other physiological processes, such as insulin secretion, vasoconstriction and nutritional status. The relationship between energy homeostasis, stress and the kisspeptinergic system in terms of regulating reproductive function is described. The clinical significance of kisspeptin, its agonists and antagonists in new therapeutic strategies for the treatment of various hormonedependent diseases of the reproductive system is substantiated. The results of the studies confirm the hypothesis that kisspeptins may participate in the regulation of anxiety-phobic states, apparently to support the emotional aspects of reproductive behavior. Given that new effects of kisspeptin are being verified, continued research in this direction opens up broad prospects for the diagnosis and treatment of various diseases.
- 11 June 2026
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 30 (2) , 364-376
Open AccessTHE KISPEPTINERGIC SYSTEM IN THE REGULATION OF REPRODUCTION, STRESS AND ENERGY HOMEOSTASIS
Study of the mechanisms of functioning of the reproductive system, the influence of sex hormones on the functions of the central nervous system and the organization of behavior is one of the urgent tasks of modern science. Kisspeptin and its receptors (Kiss-R) have been identified in lower and higher vertebrates. Recently, kisspeptin is more often considered as a behavioral hormone that affects the limbic system as a whole, including the hypothalamic-pituitary-gonadal and hypothalamicpituitary-adrenal neuroendocrine axes. In turn, these circuits regulate the activity of signaling neurotransmitters and hormones, namely gonadal steroids and stress hormones. It is known that in the central nervous system, kisspeptin acts as an endocrine regulator of sexual development and human reproductive functions. This review discusses the role of kisspeptin for the neuroendocrine regulation of gonadotropin-releasing hormone secretion. Kisspeptinergic neurons are now recognized as central regulators responsible for transmitting homeostatic information to GnRH neurons. KISS1R play a key role in initiating sexual maturation and regulating processes in the human reproductive system. Numerous studies in recent years have established the connection of kisspeptin with other physiological processes, such as insulin secretion, vasoconstriction and nutritional status. The relationship between energy homeostasis, stress and the kisspeptinergic system in terms of regulating reproductive function is described. The clinical significance of kisspeptin, its agonists and antagonists in new therapeutic strategies for the treatment of various hormonedependent diseases of the reproductive system is substantiated. The results of the studies confirm the hypothesis that kisspeptins may participate in the regulation of anxiety-phobic states, apparently to support the emotional aspects of reproductive behavior. Given that new effects of kisspeptin are being verified, continued research in this direction opens up broad prospects for the diagnosis and treatment of various diseases.
- 30 April 2026
- Published by Publishing House Helvetica (Publications) in Fitoterapia
- No. 1,p. 296-306
Study of the hepatoprotective activity of dry extract from Mahonia aquifolium (Pursh) Nutt. leaves
- 30 April 2026
- Published by Publishing House Helvetica (Publications) in Fitoterapia
- No. 1,p. 296-306
Study of the hepatoprotective activity of dry extract from Mahonia aquifolium (Pursh) Nutt. leaves
- Open Access
- 18 March 2026
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 30 (1) , 42-47
Experimental assessment of the addiction liability of N-(y-aminobutyryl)-1-aza-4,7,10,13-tetraoxacyclopentadecane hydrochloride (C-3) in rats
The safe clinical use of centrally acting analgesics remains limited by the risk of tolerance, physical dependence, and addictive behavior associated with prolonged administration. Therefore, preclinical evaluation of abuse liability represents an essential component of pharmacological screening for novel analgesic compounds. The aim of this study was to experimentally assess the addictive potential of compound C-3 (N-(γ-aminobutyryl)-1-aza-4,7,10,13-tetraoxacyclopentadecane hydrochloride) by investigating reward-related behavior, tolerance development, cross-tolerance, and withdrawal manifestations in rats. The study was conducted in adult male Wistar rats (n = 7 per group). Reward properties were evaluated using the conditioned place preference (CPP) paradigm. Antinociceptive effect and tolerance were assessed in the tail-flick test following 28-day intraperitoneal administration of C-3 (1 mg/kg), while cross-tolerance was examined after morphine administration (5 mg/kg). Statistical analysis was performed using nonparametric tests (Mann–Whitney U test, Wilcoxon signed-rank test, Friedman test; p<0.05). C-3 produced a significant antinociceptive effect, increasing latency by 58.9% compared with baseline values (p0.05). Discontinuation of chronic treatment did not induce hyperalgesia or clinically relevant signs of spontaneous withdrawal. Moreover, morphine responsiveness remained preserved after prolonged C-3 exposure, demonstrating absence of cross-tolerance and suggesting lack of long-term μ-opioid receptor desensitization. Collectively, these findings indicate a favorable addiction-related profile of C-3 under the studied dosing regimen. Further investigations should explore broader dose ranges and clarify receptor-mediated mechanisms underlying its pharmacological effects.
- 18 March 2026
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 30 (1) , 42-47
Open AccessExperimental assessment of the addiction liability of N-(y-aminobutyryl)-1-aza-4,7,10,13-tetraoxacyclopentadecane hydrochloride (C-3) in rats
The safe clinical use of centrally acting analgesics remains limited by the risk of tolerance, physical dependence, and addictive behavior associated with prolonged administration. Therefore, preclinical evaluation of abuse liability represents an essential component of pharmacological screening for novel analgesic compounds. The aim of this study was to experimentally assess the addictive potential of compound C-3 (N-(γ-aminobutyryl)-1-aza-4,7,10,13-tetraoxacyclopentadecane hydrochloride) by investigating reward-related behavior, tolerance development, cross-tolerance, and withdrawal manifestations in rats. The study was conducted in adult male Wistar rats (n = 7 per group). Reward properties were evaluated using the conditioned place preference (CPP) paradigm. Antinociceptive effect and tolerance were assessed in the tail-flick test following 28-day intraperitoneal administration of C-3 (1 mg/kg), while cross-tolerance was examined after morphine administration (5 mg/kg). Statistical analysis was performed using nonparametric tests (Mann–Whitney U test, Wilcoxon signed-rank test, Friedman test; p<0.05). C-3 produced a significant antinociceptive effect, increasing latency by 58.9% compared with baseline values (p0.05). Discontinuation of chronic treatment did not induce hyperalgesia or clinically relevant signs of spontaneous withdrawal. Moreover, morphine responsiveness remained preserved after prolonged C-3 exposure, demonstrating absence of cross-tolerance and suggesting lack of long-term μ-opioid receptor desensitization. Collectively, these findings indicate a favorable addiction-related profile of C-3 under the studied dosing regimen. Further investigations should explore broader dose ranges and clarify receptor-mediated mechanisms underlying its pharmacological effects.
- Open Access
- 1 December 2025
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 29 (4) , 722-729
Paracetamol: current views on biochemical mechanisms of toxicity and therapeutic strategies for its correction
Annotation. The purpose of the work is to systematize current data on the pathobiochemical mechanisms of damage to the body during paracetamol intoxication and to identify promising areas for the development of new pharmacological strategies for prevention and treatment. A search for information on the mechanisms of action and toxicity of paracetamol was conducted in the databases PubMed, Scopus, Web of Science, Cochrane Library, and Google Scholar. Paracetamol is one of the most widely used analgesic and antipyretic medications; however, it remains the leading cause of drug-induced liver injury worldwide. Toxicity develops as a result of excessive formation of the reactive metabolite NAPQI, generated primarily by cytochrome P450 enzymes, including CYP2E1, CYP1A2, and CYP3A4. Under physiological conditions, NAPQI is rapidly detoxified by glutathione, but during overdose its production surpasses hepatic conjugation capacity, leading to profound glutathione depletion. Accumulation of the toxic metabolite results in covalent binding to cellular proteins, disruption of calcium homeostasis, mitochondrial dysfunction, oxidative stress, activation of inflammatory signaling cascades, and hepatocyte necrosis, predominantly in centrilobular zones. The severity of poisoning depends on the ingested dose, rate of absorption, concomitant alcohol use, CYP inducers, nutritional status, age, and pre-existing liver diseases. The clinical course characteristically progresses through four phases: an initial minimally symptomatic stage; a phase of hepatic injury with rising aminotransferases; a phase of severe hepatocellular damage accompanied by coagulopathy and potential acute liver failure; and finally, a stage of recovery or progressive decompensation. N-acetylcysteine is the main and most effective antidote, acting by replenishing glutathione stores, directly binding NAPQI, reducing oxidative stress, improving microcirculation, and stabilizing mitochondrial membranes. Maximal therapeutic benefit is achieved when treatment is initiated within the first 8 hours after overdose; however, evidence indicates that N-acetylcysteine remains beneficial even at later stages. Optimization of dosing regimens, implementation of updated clinical management algorithms, and the development of sensitive biomarkers of early hepatic injury represent key directions for future research.
- 1 December 2025
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 29 (4) , 722-729
Open AccessParacetamol: current views on biochemical mechanisms of toxicity and therapeutic strategies for its correction
Annotation. The purpose of the work is to systematize current data on the pathobiochemical mechanisms of damage to the body during paracetamol intoxication and to identify promising areas for the development of new pharmacological strategies for prevention and treatment. A search for information on the mechanisms of action and toxicity of paracetamol was conducted in the databases PubMed, Scopus, Web of Science, Cochrane Library, and Google Scholar. Paracetamol is one of the most widely used analgesic and antipyretic medications; however, it remains the leading cause of drug-induced liver injury worldwide. Toxicity develops as a result of excessive formation of the reactive metabolite NAPQI, generated primarily by cytochrome P450 enzymes, including CYP2E1, CYP1A2, and CYP3A4. Under physiological conditions, NAPQI is rapidly detoxified by glutathione, but during overdose its production surpasses hepatic conjugation capacity, leading to profound glutathione depletion. Accumulation of the toxic metabolite results in covalent binding to cellular proteins, disruption of calcium homeostasis, mitochondrial dysfunction, oxidative stress, activation of inflammatory signaling cascades, and hepatocyte necrosis, predominantly in centrilobular zones. The severity of poisoning depends on the ingested dose, rate of absorption, concomitant alcohol use, CYP inducers, nutritional status, age, and pre-existing liver diseases. The clinical course characteristically progresses through four phases: an initial minimally symptomatic stage; a phase of hepatic injury with rising aminotransferases; a phase of severe hepatocellular damage accompanied by coagulopathy and potential acute liver failure; and finally, a stage of recovery or progressive decompensation. N-acetylcysteine is the main and most effective antidote, acting by replenishing glutathione stores, directly binding NAPQI, reducing oxidative stress, improving microcirculation, and stabilizing mitochondrial membranes. Maximal therapeutic benefit is achieved when treatment is initiated within the first 8 hours after overdose; however, evidence indicates that N-acetylcysteine remains beneficial even at later stages. Optimization of dosing regimens, implementation of updated clinical management algorithms, and the development of sensitive biomarkers of early hepatic injury represent key directions for future research.
- Open Access
- 30 September 2025
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 2 (43),p. 35-41
Acute toxicity and antimicrobial activity of the Plume Poppy extract (Macleaya microcarpa (Maxim.) Fedde.)
Modern medicine is facing a global problem of increasing antibiotic resistance, which significantly limits the effectiveness of traditional antibacterial drugs. This necessitates the search for new sources of antimicrobial agents, among which plant extracts containing biologically active substances with antibacterial and antifungal properties are of particular interest. The aim was a study of the acute toxicity and antimicrobial activity of Plume Poppy herb dry extract. Material and Methods. The study objects were: Plume Poppy herb, which was harvested in the Vinnytsia region during the flowering period in the summer of 2023; the dry extract of Plume Poppy herb, obtained by extraction and evaporation. The study of the acute toxicity of the Plume Poppy herb dry extract by intragastric administration to mice was carried out using the express method of T.V. Pastushenko. The study of the antimicrobial activity of the Plume Poppy herb dry extract was carried out using the disk-diffusion method and the method of two-fold serial dilutions on the basis of the Microbiology Department laboratory of National Pirogov Memorial Medical University, Vinnytsia. Results. According to the classification of K.K. Sidorov, the dry extract of Plume Poppy herb is classified as class III - moderately toxic substances. LD₅₀ was 149 mg/kg for males and 174 mg/kg for females. A pronounced direct antimicrobial activity of the Plume Poppy herb dry extract has been established. The specified extract exhibits moderate antistaphylococcal activity, acts on vegetative forms of bacilli, inhibits the growth of yeast-like fungi of the genus Candida and at the same time is less effective against gram-negative bacteria. Conclusions. The Plume Poppy herb is a source of biologically active compounds and represents a promising raw material for the development of new herbal medicinal products for external use, particularly dry extracts and their solutions with pronounced antimicrobial activity
- 30 September 2025
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 2 (43),p. 35-41
Open AccessAcute toxicity and antimicrobial activity of the Plume Poppy extract (Macleaya microcarpa (Maxim.) Fedde.)
Modern medicine is facing a global problem of increasing antibiotic resistance, which significantly limits the effectiveness of traditional antibacterial drugs. This necessitates the search for new sources of antimicrobial agents, among which plant extracts containing biologically active substances with antibacterial and antifungal properties are of particular interest. The aim was a study of the acute toxicity and antimicrobial activity of Plume Poppy herb dry extract. Material and Methods. The study objects were: Plume Poppy herb, which was harvested in the Vinnytsia region during the flowering period in the summer of 2023; the dry extract of Plume Poppy herb, obtained by extraction and evaporation. The study of the acute toxicity of the Plume Poppy herb dry extract by intragastric administration to mice was carried out using the express method of T.V. Pastushenko. The study of the antimicrobial activity of the Plume Poppy herb dry extract was carried out using the disk-diffusion method and the method of two-fold serial dilutions on the basis of the Microbiology Department laboratory of National Pirogov Memorial Medical University, Vinnytsia. Results. According to the classification of K.K. Sidorov, the dry extract of Plume Poppy herb is classified as class III - moderately toxic substances. LD₅₀ was 149 mg/kg for males and 174 mg/kg for females. A pronounced direct antimicrobial activity of the Plume Poppy herb dry extract has been established. The specified extract exhibits moderate antistaphylococcal activity, acts on vegetative forms of bacilli, inhibits the growth of yeast-like fungi of the genus Candida and at the same time is less effective against gram-negative bacteria. Conclusions. The Plume Poppy herb is a source of biologically active compounds and represents a promising raw material for the development of new herbal medicinal products for external use, particularly dry extracts and their solutions with pronounced antimicrobial activity
- Open Access
- 27 June 2025
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 29 (2) , 200-206
Evaluation of hepatoprotective properties of Tagetes Patula L extract in a model of paracetamol-ethanol hepatitis
Annotation. Drug-induced liver damage (DLD) is currently diagnosed in 5-7% of patients admitted to the hepatology department. Pharmacotherapy of DLD with registered drugs with hepatoprotective effects is not always effective, both due to the untimely start of treatment and due to the fact that known drugs cannot affect the main links of pathogenesis. A promising object for reducing the toxic effects of some drugs and ethanol on the liver can be considered a new extract of the herb of the Tagetes Patula L (EНTP), for which antioxidant, anticytolytic, membrane-protective effects have been established in previous studies. The aim of this work was to evaluate the effect of Tagetes Patula L herb extract on changes in clinical and biochemical parameters under conditions of paracetamol-ethanol hepatitis in rats. The studies were performed on a model of subacute paracetamol-ethanol hepatitis in white non-linear male rats, which were administered intragastrically daily for 2 weeks with a paracetamol suspension at a dose of 500 mg/kg and 1 ml of 40% ethanol. Ethanol was administered to potentiate the action of paracetamol. EНTP was administered at a dose of 25 mg/kg 2 weeks before pathology modeling and for 2 weeks during the reproduction of subacute hepatitis. The indicators of bile excretion, the content of bile acids and cholesterol in bile, the concentration of triglycerides in the blood, the activity of alanine aminotransferase and alkaline phosphatase were studied. The results obtained were calculated using descriptive statistics, differences were considered significant at p<0.05. Under the conditions of experimental subacute paracetamol-ethanol hepatitis, the administration of EНTP significantly normalized the bile and bile secretory function of the liver, with an increase of 3.4 times (p<0.05) in bile volume, 3.2 times (p<0.05) in bile secretion rate, 1.6 times (p<0.05) in bile bile acids, and 1.7 times (p<0.05) in bile cholesterol. A powerful anticytolytic and anti-inflammatory effect of EНTP was registered. Silymarin was inferior in effectiveness to the studied extract. According to the studied pharmacological activity, EНTP exceeds the effect of the reference drug Silymarin. Marigold herb extract is a promising object for further preclinical research with the aim of creating an effective herbal preparation based on it for the prevention and treatment of liver lesions, including DLD.
- 27 June 2025
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 29 (2) , 200-206
Open AccessEvaluation of hepatoprotective properties of Tagetes Patula L extract in a model of paracetamol-ethanol hepatitis
Annotation. Drug-induced liver damage (DLD) is currently diagnosed in 5-7% of patients admitted to the hepatology department. Pharmacotherapy of DLD with registered drugs with hepatoprotective effects is not always effective, both due to the untimely start of treatment and due to the fact that known drugs cannot affect the main links of pathogenesis. A promising object for reducing the toxic effects of some drugs and ethanol on the liver can be considered a new extract of the herb of the Tagetes Patula L (EНTP), for which antioxidant, anticytolytic, membrane-protective effects have been established in previous studies. The aim of this work was to evaluate the effect of Tagetes Patula L herb extract on changes in clinical and biochemical parameters under conditions of paracetamol-ethanol hepatitis in rats. The studies were performed on a model of subacute paracetamol-ethanol hepatitis in white non-linear male rats, which were administered intragastrically daily for 2 weeks with a paracetamol suspension at a dose of 500 mg/kg and 1 ml of 40% ethanol. Ethanol was administered to potentiate the action of paracetamol. EНTP was administered at a dose of 25 mg/kg 2 weeks before pathology modeling and for 2 weeks during the reproduction of subacute hepatitis. The indicators of bile excretion, the content of bile acids and cholesterol in bile, the concentration of triglycerides in the blood, the activity of alanine aminotransferase and alkaline phosphatase were studied. The results obtained were calculated using descriptive statistics, differences were considered significant at p<0.05. Under the conditions of experimental subacute paracetamol-ethanol hepatitis, the administration of EНTP significantly normalized the bile and bile secretory function of the liver, with an increase of 3.4 times (p<0.05) in bile volume, 3.2 times (p<0.05) in bile secretion rate, 1.6 times (p<0.05) in bile bile acids, and 1.7 times (p<0.05) in bile cholesterol. A powerful anticytolytic and anti-inflammatory effect of EНTP was registered. Silymarin was inferior in effectiveness to the studied extract. According to the studied pharmacological activity, EНTP exceeds the effect of the reference drug Silymarin. Marigold herb extract is a promising object for further preclinical research with the aim of creating an effective herbal preparation based on it for the prevention and treatment of liver lesions, including DLD.
- Open Access
- 23 March 2025
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Morphology
- Vol. 31 (1) , 12-21
Study of the effect of Saponaria officinalis herb extract on histological changes in the marginal vein of the ear under conditions of experimental thrombophlebitis
Thrombophlebitis is recognized as one of the most common complications of chronic venous insufficiency (CVI). Its course is characterized by inflammation of the venous wall and the formation of blood clots in the lower extremities of varicose veins. Thrombophlebitis is diagnosed according to various data in 5-60 % of patients with CVI. The number of drugs with a phleboprotective effect and the ability to reduce the processes of thrombus formation in veins on the pharmaceutical market of Ukraine and the world is extremely limited. As a promising object, as a new phleboprotective drug, medicinal plant raw materials can be considered, namely the extract of the herb Saponaria officinalis, for which venotonic and antiexudative effects have been established in previous studies. The aim of this work was to study the effect of Saponaria officinalis herb extract on changes in the histological parameters of the ear vein in rabbits under conditions of experimental thrombophlebitis. Experimental thrombophlebitis was modeled on rabbits according to the standard method with applying a ligature to the marginal vein of the animal's ear and injecting Lugol's solution. Histological changes after phytocomposition administration (ETML) (20 mg/kg intragastrically) were compared with the effectiveness of the reference drug Eskuvit (7.2 mg/kg for escin intragastrically). It was established that the therapeutic and prophylactic administration of ETML at a dose of 20 mg/kg significantly prevented thrombus formation in the marginal ear vein of rabbits, contributing to the softening of the thrombus material, thrombolysis, preventing the acquisition of an obliterating character for thrombotic masses. in all rabbits of the group. probably reduces the clinical indicators of transudative edema, which developed as a result of acute venostasis. ETML prevented the destruction of the vascular wall, reduced or eliminated degenerative changes and inflammatory reaction in the surrounding tissues. Significant advantages of ETML over the comparison drug Eskuvit have been established. Under the conditions of experimental thrombophlebitis, the therapeutic and prophylactic administration of ETML at a dose of 20 mg/kg has a powerful phleboprotective effect, reduces the processes of thrombus formation in the vein. The effect of ETML is statistically significantly higher than the effectiveness of the comparison drug Eskuvit.
- 23 March 2025
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Morphology
- Vol. 31 (1) , 12-21
Open AccessStudy of the effect of Saponaria officinalis herb extract on histological changes in the marginal vein of the ear under conditions of experimental thrombophlebitis
Thrombophlebitis is recognized as one of the most common complications of chronic venous insufficiency (CVI). Its course is characterized by inflammation of the venous wall and the formation of blood clots in the lower extremities of varicose veins. Thrombophlebitis is diagnosed according to various data in 5-60 % of patients with CVI. The number of drugs with a phleboprotective effect and the ability to reduce the processes of thrombus formation in veins on the pharmaceutical market of Ukraine and the world is extremely limited. As a promising object, as a new phleboprotective drug, medicinal plant raw materials can be considered, namely the extract of the herb Saponaria officinalis, for which venotonic and antiexudative effects have been established in previous studies. The aim of this work was to study the effect of Saponaria officinalis herb extract on changes in the histological parameters of the ear vein in rabbits under conditions of experimental thrombophlebitis. Experimental thrombophlebitis was modeled on rabbits according to the standard method with applying a ligature to the marginal vein of the animal's ear and injecting Lugol's solution. Histological changes after phytocomposition administration (ETML) (20 mg/kg intragastrically) were compared with the effectiveness of the reference drug Eskuvit (7.2 mg/kg for escin intragastrically). It was established that the therapeutic and prophylactic administration of ETML at a dose of 20 mg/kg significantly prevented thrombus formation in the marginal ear vein of rabbits, contributing to the softening of the thrombus material, thrombolysis, preventing the acquisition of an obliterating character for thrombotic masses. in all rabbits of the group. probably reduces the clinical indicators of transudative edema, which developed as a result of acute venostasis. ETML prevented the destruction of the vascular wall, reduced or eliminated degenerative changes and inflammatory reaction in the surrounding tissues. Significant advantages of ETML over the comparison drug Eskuvit have been established. Under the conditions of experimental thrombophlebitis, the therapeutic and prophylactic administration of ETML at a dose of 20 mg/kg has a powerful phleboprotective effect, reduces the processes of thrombus formation in the vein. The effect of ETML is statistically significantly higher than the effectiveness of the comparison drug Eskuvit.
- Open Access
- 15 January 2025
- Published by Dnipro State Medical University in Morphologia
- Vol. 18 (4) , 76-80
Effect of hydrogen sulfide donor on histological changes in the heart of rats with alcoholic cardiomyopathy
Relevance. Alcoholic cardiomyopathy is an actual problem today, because it is characterized by high prevalence and rapid development of complications. The question of effective pharmacotherapy of alcoholic heart damage remains open. The use of hydrogen sulfide donors is prospective in this direction. Aim. To evaluate the influence of hydrogen sulfide donor on histological changes of rat myocardium during experimental alcoholic cardiomyopathy in rats. Methods. Experimental studies were conducted on 30 white non-linear male rats. According to the purpose of the study, all animals were divided into three groups (10 rats each): 1st group – control; 2nd group - animals that were simulated alcoholic cardiomyopathy by intragastric administration of 20% aqueous ethanol solution (at a dose of 8 g/kg/day) for 90 days; Group 3 - rats that, after the cessation of alcoholism, were injected with the donor H2S - NaHS in a dose of 3 mg/kg/day intraperitoneally for two weeks. Histological studies of fragments of the left ventricle were carried out on the basis of the Vinnytsia Regional Pathological and Anatomical Bureau according to the generally accepted method using an Olympus BX-41 light microscope (Olympus Europe GmbH, Japan). Results. Data from histological studies showed that alcoholic cardiomyopathy is accompanied by a number of changes in the vessels of the myocardial stroma and muscle fibers. Ischemia and spasm of blood vessels, partial detachment of the endothelial layer, signs of myocardial inflammation, as well as ischemia of muscle fibers, which is accompanied by myolysis, fragmentation, abrasion of transverse striations, areas of hypertrophy, are noted. Under the conditions of using the hydrogen sulfide donor NaHS, the expressiveness of the structural changes of the myocardium initiated by alcoholic cardiomyopathy decreases: the condition of the endothelial lining of the arterioles improves, the signs of vascular spasm, myocardial inflammation, and ischemia of muscle fibers decrease. Conclusion. The conducted histological studies confirmed the presence of donor hydrogen sulfide cardioprotective properties in experimental alcoholic cardiomyopathy.
- 15 January 2025
- Published by Dnipro State Medical University in Morphologia
- Vol. 18 (4) , 76-80
Open AccessEffect of hydrogen sulfide donor on histological changes in the heart of rats with alcoholic cardiomyopathy
Relevance. Alcoholic cardiomyopathy is an actual problem today, because it is characterized by high prevalence and rapid development of complications. The question of effective pharmacotherapy of alcoholic heart damage remains open. The use of hydrogen sulfide donors is prospective in this direction. Aim. To evaluate the influence of hydrogen sulfide donor on histological changes of rat myocardium during experimental alcoholic cardiomyopathy in rats. Methods. Experimental studies were conducted on 30 white non-linear male rats. According to the purpose of the study, all animals were divided into three groups (10 rats each): 1st group – control; 2nd group - animals that were simulated alcoholic cardiomyopathy by intragastric administration of 20% aqueous ethanol solution (at a dose of 8 g/kg/day) for 90 days; Group 3 - rats that, after the cessation of alcoholism, were injected with the donor H2S - NaHS in a dose of 3 mg/kg/day intraperitoneally for two weeks. Histological studies of fragments of the left ventricle were carried out on the basis of the Vinnytsia Regional Pathological and Anatomical Bureau according to the generally accepted method using an Olympus BX-41 light microscope (Olympus Europe GmbH, Japan). Results. Data from histological studies showed that alcoholic cardiomyopathy is accompanied by a number of changes in the vessels of the myocardial stroma and muscle fibers. Ischemia and spasm of blood vessels, partial detachment of the endothelial layer, signs of myocardial inflammation, as well as ischemia of muscle fibers, which is accompanied by myolysis, fragmentation, abrasion of transverse striations, areas of hypertrophy, are noted. Under the conditions of using the hydrogen sulfide donor NaHS, the expressiveness of the structural changes of the myocardium initiated by alcoholic cardiomyopathy decreases: the condition of the endothelial lining of the arterioles improves, the signs of vascular spasm, myocardial inflammation, and ischemia of muscle fibers decrease. Conclusion. The conducted histological studies confirmed the presence of donor hydrogen sulfide cardioprotective properties in experimental alcoholic cardiomyopathy.
- Open Access
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- No. 5,p. 83-89
EFFECT OF TAGETES PATULA L. EXTRACT ON LIVER AND PANCREAS HISTOSTRUCTURE IN MODELS OF ETHANOL-PARACETAMOL HEPATITIS AND STREPTOZOTOCIN DIABETES IN RATS
Drugs are increasingly becoming predictors of the development of liver and pancreatic lesions. Drug-induced lesions are usually characterized by strong oxidative stress and destruction of hepatocyte and pancreatic cell membranes. Modern therapeutic strategies are primarily aimed at reducing clinical symptoms and are not able to exert an organoprotective effect. Medicinal plant raw materials with antioxidant and cytoprotective effects can be considered a promising object for reducing the toxic effect of some drugs on the liver and pancreas. The purpose of this work was to evaluate the effect of extract herb Tagetes patula L (EHTP) on changes in histological parameters under conditions of ethanol-paracetamol hepatitis and streptozotocin diabetes. Materials and methods. Experimental ethanol-paracetamol hepatitis and streptozotocin diabetes were modeled in rats using standard methods. The investigated EHTP and the reference drug Silymarin were administered at a dose of 25 mg/kg in a therapeutic and prophylactic regimen. Organ samples (liver in the first experiment and pancreas in the second) were fixed in 10% formalin, dehydrated in ascending grades of alcohol, embedded in paraffin. Sections 6–7 μm thick were obtained using a sliding microtome, mounted on glass slides, stained with hematoxylin and eosin. Results. The EHTP has a noticeable protective effect under the conditions of ethanol-paracetamol hepatitis, which is manifested in a significant reduction in the degree of hydropic and fatty degeneration of hepatocytes, disorders of internal hemodynamics, inflammatory reaction; normalization of the structure and morphological integrity of cells. In the model of streptozotocin diabetes, the EHTP reduces destructively dystrophically altered pancreatic cells and exhibits anti-inflammatory effects, significantly reducing signs of insulitis and inflammatory reaction in the interacinar tissue. Conclusions. The EHTP has a significant organoprotective effect, with a protective effect on hepatocytes in conditions of ethanol- paracetamol hepatitis and on pancreatic cells in conditions of streptozotocin diabetes. У роботі оцінено вплив екстракту трави чорнобривців розлогих (Tagetes patula L) на гістологічні зміни за умов етанол-парацетамолового гепатиту та стрептозотоцинового діабету. Досліджуваний cухий екстракт трави чорнобривців розлогих (ЕТЧР) та референс-препарат Силімарин вводили в дозі 25 мг/кг у лікувально-профілактичному режимі. Встановлено, що ЕТЧР чинить помітну захисну дію за умов етанол-парацетамолового гепатиту, зменшує ступінь гідропичної і жирової дистрофії гепатоцитів, розлади внутрішньої гемодинаміки, запальну реакцію; сприяє нормалізації структури і морфологічній цілісності клітин. На моделі стрепто-зотоцинового діабету ЕТЧР зменшує деструктивно-дистрофічно змінені клітини підшлункової залози проявляє протизапальну дію, тобто ЕТЧР чинить виразну органопротекторну дію на печінку за умов етанол-парацетамолового гепатиту та на підшлункову залозу за умов стрептозотоцинового діабету.
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- No. 5,p. 83-89
Open AccessEFFECT OF TAGETES PATULA L. EXTRACT ON LIVER AND PANCREAS HISTOSTRUCTURE IN MODELS OF ETHANOL-PARACETAMOL HEPATITIS AND STREPTOZOTOCIN DIABETES IN RATS
Drugs are increasingly becoming predictors of the development of liver and pancreatic lesions. Drug-induced lesions are usually characterized by strong oxidative stress and destruction of hepatocyte and pancreatic cell membranes. Modern therapeutic strategies are primarily aimed at reducing clinical symptoms and are not able to exert an organoprotective effect. Medicinal plant raw materials with antioxidant and cytoprotective effects can be considered a promising object for reducing the toxic effect of some drugs on the liver and pancreas. The purpose of this work was to evaluate the effect of extract herb Tagetes patula L (EHTP) on changes in histological parameters under conditions of ethanol-paracetamol hepatitis and streptozotocin diabetes. Materials and methods. Experimental ethanol-paracetamol hepatitis and streptozotocin diabetes were modeled in rats using standard methods. The investigated EHTP and the reference drug Silymarin were administered at a dose of 25 mg/kg in a therapeutic and prophylactic regimen. Organ samples (liver in the first experiment and pancreas in the second) were fixed in 10% formalin, dehydrated in ascending grades of alcohol, embedded in paraffin. Sections 6–7 μm thick were obtained using a sliding microtome, mounted on glass slides, stained with hematoxylin and eosin. Results. The EHTP has a noticeable protective effect under the conditions of ethanol-paracetamol hepatitis, which is manifested in a significant reduction in the degree of hydropic and fatty degeneration of hepatocytes, disorders of internal hemodynamics, inflammatory reaction; normalization of the structure and morphological integrity of cells. In the model of streptozotocin diabetes, the EHTP reduces destructively dystrophically altered pancreatic cells and exhibits anti-inflammatory effects, significantly reducing signs of insulitis and inflammatory reaction in the interacinar tissue. Conclusions. The EHTP has a significant organoprotective effect, with a protective effect on hepatocytes in conditions of ethanol- paracetamol hepatitis and on pancreatic cells in conditions of streptozotocin diabetes. У роботі оцінено вплив екстракту трави чорнобривців розлогих (Tagetes patula L) на гістологічні зміни за умов етанол-парацетамолового гепатиту та стрептозотоцинового діабету. Досліджуваний cухий екстракт трави чорнобривців розлогих (ЕТЧР) та референс-препарат Силімарин вводили в дозі 25 мг/кг у лікувально-профілактичному режимі. Встановлено, що ЕТЧР чинить помітну захисну дію за умов етанол-парацетамолового гепатиту, зменшує ступінь гідропичної і жирової дистрофії гепатоцитів, розлади внутрішньої гемодинаміки, запальну реакцію; сприяє нормалізації структури і морфологічній цілісності клітин. На моделі стрепто-зотоцинового діабету ЕТЧР зменшує деструктивно-дистрофічно змінені клітини підшлункової залози проявляє протизапальну дію, тобто ЕТЧР чинить виразну органопротекторну дію на печінку за умов етанол-парацетамолового гепатиту та на підшлункову залозу за умов стрептозотоцинового діабету.
- Open Access
- 14 March 2024
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 28 (1) , 29-34
Phleboprotective effect of Saponaria officinalis herbs extract under conditions of experimental venostasis
Annotation. Chronic venous insufficiency has held the leading positions for the last 50 years in the general list of human diseases and has a significant specific weight in the group of cardiovascular pathologies. The number of drugs with phleboprotective effect on the pharmaceutical market of Ukraine and the world is extremely limited. Medicinal plant raw materials with venoconstrictor, antioxidant action and the ability to prevent blood clots can be considered as a promising object as a new phleboprotective medicinal product. The aim of this work was to study the effect of Saponaria officinalis herb extract under conditions of experimental venostasis. Experimental male rats weighing 180-220 g were simulated venostasis by placing a ligature on the tail vein. The dynamics of tail volume increase during 6 hours and the involution of edema after 1, 2, 17 and 24 hours were recorded, as well as blood coagulation time, prothrombin and thrombin time were determined. The researched extract of the common soapwort herb (ECSH) was administered intragastrically at a dose of 20 mg/kg. The comparison drug Eskuvit at a dose of 7.2 mg/kg according to escin. Statistical analysis was performed using descriptive statistics using Microsoft Excel and the Statistica 6.0 package. Convergences were considered favorable at p≤0.05. It was established that the therapeutic and prophylactic administration of ECSH at a dose of 20 mg/kg probably reduces the clinical indicators of transudative edema, which developed as a result of acute venostasis. Administration of ECSH normalizes indicators of general blood coagulation to the level of physiological limits. Therefore, the therapeutic and prophylactic administration of ECSH at a dose of 20 mg/kg during experimental venostasis with transudative edema and increased thrombus formation exerts a powerful phleboprotective effect, which statistically significantly exceeds the effectiveness of the comparison drug Eskuvit. Further studies of anti-inflammatory, membrane-stabilizing, antimicrobial and reparative activity will allow forming the pharmacological profile of ECSH as a potential phleboprotective drug. Анотація. Хронічна венозна недостатність утримує лідерські позиції останні 50 років у загальному переліку захворювань людини та має значну питому вагу у групі серцево-судинних патологій. Кількість лікарських препаратів із флебопротекторною дією на фармацевтичному ринку України та світу вкрай обмежена. Перспективним новим флебопротекторним лікарським засобом можна вважати лікарську рослинну сировину із веноконстрикторною, антиоксидантною дією та здатністю попереджувати тромбоутворення. Мета роботи – вивчити вплив екстракту трави Saponaria officinalis за умов експериментального веностазу. Експериментальним щурам-самцям масою 180-220 г моделювали веностаз накладанням лігатури на хвостову вену. Реєстрували динаміку приросту об’єму хвоста протягом 6 годин та інволюцію набряку через 1, 2, 17 і 24 години, а також визначали час згортання крові, протромбіновий і тромбіновий час. Досліджуваний екстракт трави мильнянки лікарської (ЕТМЛ) вводили інтрагастрально у дозі 20 мг/кг. Препарат порівняння Ескувіт у дозі 7,2 мг/кг за есцином. Статистичний аналіз проводили методами дескрипційної статистики за допомогою Microsoft Excel та пакету Statistica 6.0. Poзбiжнocтi ввaжaлиcя вipoгiдними пpи p≤0,05. Встановлено, що лікувально-профілактичне введення ЕТМЛ у дозі 20 мг/кг вірогідно знижує клінічні показники транссудативного набряку, який розвинувся внаслідок гострого веностазу. Введення ЕТМЛ нормалізує до рівня фізіологічних меж показники загального згортання крові. Отже, лікувально-профілактичне введення ЕТМЛ у дозі 20 мг/кг за експериментального веностазу із транссудативним набряком та підвищенням тромбоутворення чинить потужну флебопротекторну дію, яка статистично значуще перевищує ефективність препарату порівняння Ескувіту. Подальші дослідження протизапальної, мембраностабілізуючої, протимікробної та репаративної активності дозволять сформувати фармакологічне досьє ЕТМЛ як потенційного флебопротекторного лікарського засобу.
- 14 March 2024
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 28 (1) , 29-34
Open AccessPhleboprotective effect of Saponaria officinalis herbs extract under conditions of experimental venostasis
Annotation. Chronic venous insufficiency has held the leading positions for the last 50 years in the general list of human diseases and has a significant specific weight in the group of cardiovascular pathologies. The number of drugs with phleboprotective effect on the pharmaceutical market of Ukraine and the world is extremely limited. Medicinal plant raw materials with venoconstrictor, antioxidant action and the ability to prevent blood clots can be considered as a promising object as a new phleboprotective medicinal product. The aim of this work was to study the effect of Saponaria officinalis herb extract under conditions of experimental venostasis. Experimental male rats weighing 180-220 g were simulated venostasis by placing a ligature on the tail vein. The dynamics of tail volume increase during 6 hours and the involution of edema after 1, 2, 17 and 24 hours were recorded, as well as blood coagulation time, prothrombin and thrombin time were determined. The researched extract of the common soapwort herb (ECSH) was administered intragastrically at a dose of 20 mg/kg. The comparison drug Eskuvit at a dose of 7.2 mg/kg according to escin. Statistical analysis was performed using descriptive statistics using Microsoft Excel and the Statistica 6.0 package. Convergences were considered favorable at p≤0.05. It was established that the therapeutic and prophylactic administration of ECSH at a dose of 20 mg/kg probably reduces the clinical indicators of transudative edema, which developed as a result of acute venostasis. Administration of ECSH normalizes indicators of general blood coagulation to the level of physiological limits. Therefore, the therapeutic and prophylactic administration of ECSH at a dose of 20 mg/kg during experimental venostasis with transudative edema and increased thrombus formation exerts a powerful phleboprotective effect, which statistically significantly exceeds the effectiveness of the comparison drug Eskuvit. Further studies of anti-inflammatory, membrane-stabilizing, antimicrobial and reparative activity will allow forming the pharmacological profile of ECSH as a potential phleboprotective drug. Анотація. Хронічна венозна недостатність утримує лідерські позиції останні 50 років у загальному переліку захворювань людини та має значну питому вагу у групі серцево-судинних патологій. Кількість лікарських препаратів із флебопротекторною дією на фармацевтичному ринку України та світу вкрай обмежена. Перспективним новим флебопротекторним лікарським засобом можна вважати лікарську рослинну сировину із веноконстрикторною, антиоксидантною дією та здатністю попереджувати тромбоутворення. Мета роботи – вивчити вплив екстракту трави Saponaria officinalis за умов експериментального веностазу. Експериментальним щурам-самцям масою 180-220 г моделювали веностаз накладанням лігатури на хвостову вену. Реєстрували динаміку приросту об’єму хвоста протягом 6 годин та інволюцію набряку через 1, 2, 17 і 24 години, а також визначали час згортання крові, протромбіновий і тромбіновий час. Досліджуваний екстракт трави мильнянки лікарської (ЕТМЛ) вводили інтрагастрально у дозі 20 мг/кг. Препарат порівняння Ескувіт у дозі 7,2 мг/кг за есцином. Статистичний аналіз проводили методами дескрипційної статистики за допомогою Microsoft Excel та пакету Statistica 6.0. Poзбiжнocтi ввaжaлиcя вipoгiдними пpи p≤0,05. Встановлено, що лікувально-профілактичне введення ЕТМЛ у дозі 20 мг/кг вірогідно знижує клінічні показники транссудативного набряку, який розвинувся внаслідок гострого веностазу. Введення ЕТМЛ нормалізує до рівня фізіологічних меж показники загального згортання крові. Отже, лікувально-профілактичне введення ЕТМЛ у дозі 20 мг/кг за експериментального веностазу із транссудативним набряком та підвищенням тромбоутворення чинить потужну флебопротекторну дію, яка статистично значуще перевищує ефективність препарату порівняння Ескувіту. Подальші дослідження протизапальної, мембраностабілізуючої, протимікробної та репаративної активності дозволять сформувати фармакологічне досьє ЕТМЛ як потенційного флебопротекторного лікарського засобу.